Emgality

Emgality (Galcanezumab) is a prescription medication used for migraine prevention. This subcutaneous injection is designed to reduce the frequency of migraine episodes in eligible patients.

Emgality is primarily used for the preventive treatment of migraines. It is not intended for acute migraine relief but aims to reduce the number of migraine days experienced by patients. The medication works by targeting a specific protein involved in the pathogenesis of migraines, helping to manage this neurological condition over time.

Common effects of Emgality may include injection site reactions such as redness, pain, or swelling. Some users might experience nausea, fatigue, or constipation. These effects vary among individuals and are not experienced by everyone who uses the medication.

Emgality should be used under the supervision of a healthcare provider. It is important to inform your healthcare provider about any allergies or medical conditions before starting treatment. The medication should be stored as directed to maintain its efficacy.

Emgality may interact with other medications, including those that affect the immune system or blood pressure. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.